Novartis Begins CAR-T Payment Experiments With Outcomes-Based Contract With CMS

 
• By Cathy Kelly
  
3d illustration of T cells or cancer cells
Novartis's Kymriah will be reimbursed under a groundbreaking arrangement
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access